News | June 11, 2026
DFE Pharma wins third straight EcoVadis Gold Medal
The award places the company in the top 5% globally
The award places the company in the top 5% globally
Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery
Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer
Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio
The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities
The acquisition of Milan-based company will strengthen subsidiary Alivira Animal Health’s presence in Europe
The landmark legislation has laid the foundation for a skilled, regulated and globally competitive Allied and Healthcare Professional workforce, reshaping healthcare education and delivery across India
The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year
The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format
Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
